What is the best pharmacologic treatment for sickle cell disease pain crises? (abre una nueva ventana)

Baker M, Hafner JW.

Fuente‎: Ann Emerg Med 2012;59(6):515-6.

Indexado en‎: PubMed 22221839

DOI‎: 10.1016/j.annemergmed.2011.11.026

https://www.ncbi.nlm.nih.gov/pubmed/22221839 (abre una nueva ventana)

Update on pain management in sickle cell disease. (abre una nueva ventana)

Ballas SK.

Fuente‎: Hemoglobin 2011;35(5-6):520-9.

Indexado en‎: PubMed 21910604

DOI‎: 10.3109/03630269.2011.610478

https://www.ncbi.nlm.nih.gov/pubmed/21910604 (abre una nueva ventana)

Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (abre una nueva ventana)

Qari MH, Aljaouni SK, Alardawi MS, Fatani H, Alsayes FM, Zografos P, Alsaigh M, Alalfi A, Alamin M, Gadi A, Mousa SA.

Fuente‎: Thromb Haemost 2007;98(2):392-6.

Indexado en‎: PubMed 17721622

https://www.ncbi.nlm.nih.gov/pubmed/17721622 (abre una nueva ventana)

Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. (abre una nueva ventana)

Tanabe P, Hafner JW, Martinovich Z, Artz N.

Fuente‎: Acad Emerg Med 2012;19(4):430-8.

Indexado en‎: PubMed 22506947

DOI‎: 10.1111/j.1553-2712.2012.01330.x

https://www.ncbi.nlm.nih.gov/pubmed/22506947 (abre una nueva ventana)

Management of sickle cell disease. (abre una nueva ventana)

de Montalembert M.

Fuente‎: BMJ 2008;337:a1397.

Indexado en‎: PubMed 18779222

https://www.ncbi.nlm.nih.gov/pubmed/18779222 (abre una nueva ventana)

Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (abre una nueva ventana)

Okomo U, Meremikwu MM.

Fuente‎: Cochrane Database Syst Rev 2012;(6):CD005406.

Indexado en‎: PubMed 22696351

DOI‎: 10.1002/14651858.CD005406.pub3

https://www.ncbi.nlm.nih.gov/pubmed/22696351 (abre una nueva ventana)

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. (abre una nueva ventana)

Ip H, Kesse-Adu R, Howard J, Hart N.

Fuente‎: Br J Haematol 2013;161(3):455-6.

Indexado en‎: PubMed 23419066

DOI‎: 10.1111/bjh.12254

https://www.ncbi.nlm.nih.gov/pubmed/23419066 (abre una nueva ventana)

Guidelines for the management of the acute painful crisis in sickle cell disease. (abre una nueva ventana)

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Fuente‎: Br J Haematol 2003;120(5):744-52.

Indexado en‎: PubMed 12614204

https://www.ncbi.nlm.nih.gov/pubmed/12614204 (abre una nueva ventana)

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (abre una nueva ventana)

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Fuente‎: Diving Hyperb Med 2012;42(2):82-4.

Indexado en‎: PubMed 22828815

https://www.ncbi.nlm.nih.gov/pubmed/22828815 (abre una nueva ventana)

Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (abre una nueva ventana)

Ballas SK, Files B, Luchtman-Jones L, Benjamin L, Swerdlow P, Hilliard L, Coates T, Abboud M, Wojtowicz-Praga S, Grindel JM.

Fuente‎: Hemoglobin 2004;28(2):85-102.

Indexado en‎: PubMed 15182051

https://www.ncbi.nlm.nih.gov/pubmed/15182051 (abre una nueva ventana)

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (abre una nueva ventana)

Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL.

Fuente‎: N Engl J Med 1995;333(11):699-703.

Indexado en‎: PubMed 7637747

DOI‎: 10.1056/NEJM199509143331104

https://www.ncbi.nlm.nih.gov/pubmed/7637747 (abre una nueva ventana)

Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (abre una nueva ventana)

Chang WL, Corate LM, Sinclair JM, van der Heyde HC.

Fuente‎: J Investig Med 2008;56(8):1023-7.

Indexado en‎: PubMed 19050460

DOI‎: 10.2310/JIM.0b013e31818cb612

https://www.ncbi.nlm.nih.gov/pubmed/19050460 (abre una nueva ventana)

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (abre una nueva ventana)

Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA.

Fuente‎: N Engl J Med 2000;342(25):1855-65.

Indexado en‎: PubMed 10861320

DOI‎: 10.1056/NEJM200006223422502

https://www.ncbi.nlm.nih.gov/pubmed/10861320 (abre una nueva ventana)